Home  /  Resource Library  /  Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial

Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial

This study reported the resolution of peripheral neuropathy with patients participating in a phase III clinical trial of Brentuximab Vedotin and chemotherapy for first line treatment of Hodgkin lymphoma.